尖吻蝮蛇毒去整合素的分离纯化及活性测定
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
目的从尖吻蝮蛇毒中分离纯化一种小分子多肽,研究其理化性质,对ADP、胶原、凝血酶诱导的血小板聚集以及对血管生成的影响。方法经Sephadex G-75凝胶过滤,超滤,DEAE-Sepharose CL-6B离子交换层析法分离纯化蛇毒组分,暂命名为K组分,采用高效液相鉴定纯度,用SDS-聚丙烯酰胺凝胶电泳(SDS-PAGE)测定其分子量,等电聚焦法测定等电点,用比浊法测定其抗血小板聚集活性,流式细胞术分析该组分与血小板GPⅡb/Ⅲa的作用,酶联免疫吸附实验测血浆中GMP-140含量,电镜下观察K组分对血小板超微结构的影响,建立鸡胚绒毛尿囊膜模型测定其抗血管生成活性。
     结果从尖吻蝮蛇毒中分离相对分子量约为7862D等电点为4.29的组分。紫外扫描发现,K组分在200-230nm处有最大吸收。该组分能抑制由ADP、胶原、凝血酶诱导的血小板聚集并成剂量依赖性;剂量依赖性抑制FITC - CD41a与血小板GPⅡb/Ⅲa的结合;能减轻血小板超微结构的损伤程度;具有抑制鸡胚尿囊膜血管生成的作用。结论此法成功地从尖吻蝮蛇毒中纯化出去整合素。该组分有很强的抗血小板聚集作用。
AIM To purify a disintegrin from Agkistrodon Acutus snake venom , and to study the physical and chemical properties of the peptide, as well as its effects on the platelet aggregation stimulated by ADP, collagen, and thrombin. Method To extract snake venom through Superdex 75 gel filtration, ultrafiltration and DEAE -Sepharose CL-6B ionexchange. The purified product was identified by HPLC C18. The molecular weight was determined by SDS- polyacrylamid gel electrphoresis. The isoelectric point was estimated by the isoelectric focusing electrophoresis. Platelet aggragation was measured by nephelometry. The effect of fraction K on GPⅡb/Ⅲa was detected by flow eytometry. The level of GMP-140 in plasma was measured by ELISA. The ultrastructures of platelet were observed as well. The antiangiogenesis effect in vivo of fraction K on CAM assay was observed. Result The molecular weight of a small peptide purified from Agkistrodon Acutus snake venom was 7862D. Its isoelectric point was pH4.29. This peptide could dose-dependently inhibit the platelet aggregation induced by ADP, collagen and thrombin,and the binding reaction of fluorescein isothiocyanate (FITC)-conjugated CD41a.The peptide could lighten the disruption of platelets ultrastructure and inhibit the spontaneous angiogenesis of CAM. And it had no effect on GMP-140 in plasma. Conclusion The method has been proved to be successful for the purification of disintegrin that inhibits platelet aggregation.
引文
1.张维文,张贵平,罗健东,钟蓓华等.眼镜王蛇毒中酸性磷脂酶A2对三氯化铁诱导的大鼠动脉血栓形成的抑制作用.中国药理学与毒理学杂志,2004,18(1):37-41.
    2.王晓辉,王化丽,李旭.尖吻蝮蛇蛇毒中镇痛成分的研究. 中国生化药物杂志,2001,22(4):198-199.
    3.倪永兵,张孝清,肖继皋.中国福建尖吻蝮蛇蛇毒类凝酶止血作用的实验研究. 南京医科大学学报,2001,21(6):515-517.
    4.Pu X C, Wong P T, Gopalakri shnakone P. A nove1 ana1gesic toxin (hannalge sin) f rom the venome of king cobra (ophiophagus Hannah). Toxicon,1995,33(11): 1425-1431.
    5.孙德军,谷红东,杨春伟,赵轶卓等.去整合蛋白及其抗肿瘤作用研究进展.吉林大学学报,2003, 29(6):860-863.
    6.Huang T-F, Holt JC, Lukasiewicz H, Niewiarowski S.Trigramin: A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb/IIIa complex. J Biol Chem., Nov 1987;262( 33); 16157-16163.
    7.Perutelli P. Disintegrins: potent inhibitors of platelet aggregation. Recenti Prog Med, Apr 1995; 86(4): 168-74.
    8.Schagger H,Jagrow G.Tricine-sodium dodecyl sulfate-polyacry -lamide gel electrophoresis for the separation of proteins in the range from 1 to 100KDa.Anal Biochem,1987;166(2):368-397.
    9.Matsui T,Fujimura Y,Titani K.Snake venom proteases affecting hemostasis and thrombosis.Biochim Biophys Acta, 2000; 1477(1-2): 146-56
    10.范礼斌,冉永禄.五步蛇蛇毒磷酯酶 A2 的纯化及部分性质.生物化学杂志.1992;8(6):741-7.
    11.朱正光,吴曙光.一种水解血小板膜糖蛋白 GPIb 的眼镜蛇毒组分的分离纯化与鉴定.中国药理学通报,1999;15(6):563-6.
    12.中华人民共和国药典委员会.中华人民共和国药典.北京:化学工业出版社.1995(二部)
    13.Hong SY, Sohn YD, Chung KH, Kim DS.Structural and functional significance of disulfide bonds in saxatilin, a 7.7 kDa disintegrin.Biochem Biophys Res Commun, Apr 2002; 293(1): 530-6.
    14.Marcinkiewicz C, Vijay-Kumar S, McLane MA et al.Significance of RGDLoop and C-Terminal Domain of Echistatin for Recognition of IIb 3 and v 3Integrins and Expression of Ligand-Induced Binding Site[J].Blood,1997;90(4):1565-75
    15.Eble JA, Beermann B, Hinz HJ, Schmidt-Hederich A .Alpha 2beta 1 integrin is not recognized by rhodocytin but is the specific, high affinity target of rhodocetin, an RGD-independentdisintegrin and potent inhibitor of cell adhesion to collagen.J Biol Chem. 2001; 276(15):12274-84.
    16.McLane MA, Marcinkiewicz C, Vijay-Kumar S, Wierzbicka-Patynowski I, Niewiarowski S.Viper venom disintegrins and related molecules.Proc Soc Exp Biol Med, Nov 1998; 219: 109 - 119.
    17.王振义,李家增,阮长耿,宋善俊等.血栓与止血.上海科学技术出版社,1995.42.
    18.Folkman J.Clinical application of research on angiogenesis.N Engl J Med,1995,333:1757-1763.
    19.Gimbroney M,Grtan RS,Folkman J,et al.Tumor growth neovasculari- cation:an experimental model using rabbit comea.J Nztl Cancer Inst,1974,52:413-427.
    20.Jain RK,Schlenger K,Hockel M,et al.Quantitative angiogenesis assays:progress and problems.Nature Medicine,1997,3:1203-1208.
    21.Peek MJ,Norman TM,Morgan C,et al.The chick chorioallantoic membrane assay:an improved technique for the study of angiogenic activity.ExpPathol,1988,34:35-40.
    22.Yeh CH, Peng HC, Yih JB, Huang TF. A new short chain RGD-containing disintegrin,accutin,inhibits the common pathway of human platelet aggregation.Biochim Biophys Acta, 1998;1425(3):493-504
    23.Yeh CH, Peng HC, Huang TF. Accutin, a New Disintegrin, Inhibits Angiogenesis In Vitro and In Vivo by Acting as Integrin v 3 Antagonist and Inducing Apoptosis. Blood, Nov 1998; 92(9): 3268- 3276
    1.McLane MA, Marcinkiewicz C, Vijay-Kumar S,Wierzbicka- Patynowski I, Niewiarowski S.Viper venom disintegrins and related molecules. Proc Soc Exp Biol Med, Nov 1998; 219: 109 - 119.
    2.Perutelli P .Disintegrins: potent inhibitors of platelet aggregation. Recenti Prog Med, Apr 1995; 86(4): 168-74.
    3.Huang T-F, Holt JC, Lukasiewicz H, Niewiarowski S.Trigramin: A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb/IIIa complex. J Biol Chem., Nov 1987;262( 33); 16157-16163.
    4.Moreno-Murciano MP, Daniel Monleón, Juan J. Calvete, Bernardo Celda, Cezary Marcinkiewicz.Amino acid sequence and homology modeling of obtustatin, a novel non-RGD-containing short disintegrin isolated from the venom of Vipera lebetina obtusa. Protein Sci., Feb 2003; 12: 366 - 371.
    5.Calvete JJ,Moreno-Murciano MP,Theakston RD et al.Snake venom disintegrins:novel dimeric disintegrins and structural diversification by disulphide bond engineering.Biochem J,2003,372(Pt 3):725-34.
    6.Okuda D,Koike H,Morita T.A new gene structure of the disintegrin family:a subunit of dimeric disintegrin has a short coding region. Bioche mistry,2002, 41 (48):14248-54.
    7.Zhou XD,Jin Y,Chen RQ et al.Purification,cloning and biological characterization of a novel disintegrin from Trimeresurus jerdonii venom. Toxicon,2004,43(1):69-75.
    8.Yeh CH,Peng HC,Yih JB et al.A new short chain RGD-containing disintegrin, accutin,inhibits the common pathway of human plateletaggregation.Biochim Biophys Acta,1998,1425(3):439-504.
    9.Wang R,Kini RM,Chung MC.Rhodocetin,a novel platelet aggregation inhibitor from the venom of Calloselasma rhodostoma(Malayant pit viper);Synergistic and noncovalent interaction between its subunits. Biochemistry,1999,38(23) :7584-93.
    10.Cominetti MR,Ribeiro JU,Fox JW et al.BaG,a new dimeric metalloproteinase/disintegrin from the Bothrops alternatus snake venom that interacts with alpha5betal integrin.Arch Biochem BIOPHYS,2003,416(2):171-9
    11.Calvete JJ,Fox JW ,Agelan A et al.The presence of the WGD motif in CC8 heterodimeric disintegrin increases its inhibitory effect on alphaII(b)beta3,alpha(v)beta3,and alpha5betal integrins. Biochemistry, 2002, 41(6) : 2014-21.
    12.Marcinkiewicz C,Vijay-Kumar S,Melane MA et al.Significance of RGD loop and C-terminal domain of echistatin for recognition of alphaⅡ b beta3 and alpha(v) beta3 integrins and expression of ligand-induced binding site.Blood,1997,90(4):1565-75.
    13.Atkinson RA,Saudek V,Peton JT.Echistatin:the refined structure of a disintegrin insolution by 1H NMR and restrained molecular dynamics.Int J Pept Protein Res,1994;43(6):563-72.
    14.Adler M,Lazarus RA,Dennis MS et al.Solution structure of kistrin,a potent platelet aggregation inhibitor and GPⅡb-Ⅲa antagonist. Science,1991,253(5018):445-8.
    15.Maruyama K,Kawasaki T,Sakai Y et al.Isolation and amino acid sequence of flavostatin,a novel disintegrin from the venom of Trimeresurus flavoviridis.Peptides,1997,18(1):73-8.
    16.Smith KJ,Jaseja M,Lu X et al.Three-dimensional structure of the RGD –Containing snake toxin albolabrin in solution,based on 1HNMR spectroscopy and simulated annealing calculatons.Int J Pept Protein Res, 1996,48(3):220-8
    17.Scarborough RM, Rose JW, Hsu MA, Phillips DR, Fried VA, Campbell AM, Nannizzi L, Charo IF. Barbourin:A GPIIb-IIIa-specific integrin antagonist from the venom of Sistrurus m. barbouri. J Biol Chem., May 1991; 266: 9359 - 9362.
    18.Scarborough RM, Naughton MA, Teng W, Rose JW, Phillips DR, Nannizzi L, Arfsten A, Campbell AM, Charo IF.Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb-IIIa.J Biol Chem., Jan 1993; 268: 1066 - 1073.
    19.Cezary Marcinkiewicz, Juan J. Calvete, Mariola M. Marcinkiewicz, Manfred Raida, Senadhi Vijay-Kumar, Ziwei Huang, Roy R. Lobb, Stefan Niewiarowski.EC3, a Novel Heterodimeric Disintegrin from Echis carinatus Venom, Inhibits 4 and 5 Integrins in an RGD-independent Manner.J Biol Chem., Apr 1999; 274: 12468 – 12473
    20.Calevet JJ,Moreno-Murciano MP,Theakston RD et al.Snake venom disintegrins:novel dimeric disintegrins and structural diversification by disulphide bond engineering.Biochem J,2003,372(Pt3):725-34.
    21.Calvete JJ,Shafer W,Soszka T et al.Identification of the disulfide bond pattern in albolabrin,an RGD-containing peptide from the venom of Trimeresurus albolabris:significance for the expression of platelet aggregation inhibitory activity Biochemistry, 1991, 30(21):5225-9.
    22.Paz Moreno-Murciano M,Monleon D,Marcinkiewicz C et al.NMR solution structure of the non-RGD disintegrin obtustatin.J Mol Biol,2003, 329(1):135-45.
    23.Shin J,Hong SY,Chung K et al .Solution structure of a novel disintegrin,salmosin,from Agkistrodon halys venom. Biochemistry, 2003, 42 (49):14408-15
    24.Monleon D,Moreno-Murciano MP et al.Concerted motions of the integrin-binding loop and the C-terminal tail of the non-RGD disintegrin obtustatin.J Biol Chem,2003,278(46):45570-6.
    25.Fujii Y,Okuda D,Fujimoto Z et al.Crystal Structure of trimestatin, a disintegrin containing a cell adhesion recognition motif RGD.J Mol Biol, 2003, 332(5);1115-22.
    26.Siddiqi AR,Persson B,Zaidi ZH,et al.Characterization of teo platelet aggregation inhibitor-like polypeptides from viper venom. Peptides, 1992, 13:1033-1037.
    27.Niewiarowski S, McLane MA, Kloczewiak M, Stewart GJ..Disintegrins and other naturally occurring antagonists of platelet fibrinogen receptors.Semin Hematol, Oct 1994; 31(4): 289-300.
    28.Gould RJ, Polokoff MA, Friedman PA, Huang TF, Holt JC, Cook JJ, Niewiarowski S.Disintegrins: a family of integrin inhibitory proteins from viper venoms.Proc Soc Exp Biol Med, Nov 1990; 195: 168 - 171.
    29.Sheu JR,Yen MN,Hung WC,et al.Triflavis inhibits platelet-induced vasoconstriction in de-endothelialized aorn arterioseler.Thromb Vasc Biol,1997,17:3461-3468
    30.Tsai TJ,Sheu JR,Chen YM,et al.Disintegrin modulates rat glomerular messangial cell behavior.Nephrom,1995,70:83-90.
    31.Yang CH,Huang TF,Liu KR,et al Inhibition of retinal pigment epithelial cell-induced tractional tetinal detachm cat by distintegrins,a group of Arg-Gly-Asp-containing peptides from viper venom.Invest Ophthalmol Vis Sci,1996,37:843-854
    32.任琛. 杨奎.作用于血小板膜GP Ⅱb/Ⅲa的蛇毒血小板聚集抑制剂的研究及其进展。国外医学.输血及血液学分册 1999;22(5):324-328
    33.方全.整合素与血管生成。国外医学免疫学分册。2002;25(1);17-20.
    34.Eliceiri BP,Cheresh DA.Role of alpha v integrins during angiogenesis.Cancer J,2000;6Suppl 3:S245-9.
    35.Yeh CH,Peng HC,Huang TF.Accutin,a new disintegrin,inhibits angiogenesis in vitro and in vivo by acting as integrin alpha v beta 3 antagonist and inducing apoptosis. Blood, 1998; 92(9):3268-76.
    36.Kang IC,Lee YD,Kim DS.A novel disintegrin salmosin inhibits tumor angiogenesis.Cancer Res.1999;59(15):3754-60
    37.Sato M,Sardana MK,Grasser WA,et al.Echistatin is a potent inhibitor of bone resorption in culture.J Cell Biol,1990; 111:1717-1723
    38.Sato M,Garsky V,Majeska RJ,et al.Structure-activity studies of the s-echistatin inhibition of bone resorption.J Bone Miner Res. 1994;9;1441-1449
    39.Fisher JE,Caulfield MP,Sato M,et al.Inhibtion of osteoclastic bone resorption in vivo by echistatin,an arginyl- glycyl- aspartyl(RGD)–containing protein. Endocrinoligy, 1993;132; 1411-1413
    40.King KL,Danza JJ,Bodary S,et al.Effect of kistrin on bone resorption in vitro and serum calcium in vitro.J Bone Min Res,1994;9;381-387
    41.Yang CH,Huang TF,Liu KR,et al.Inhibition of retinal pigment epithelial cell-induced tractiona retinal detachment by disintegrins,a group of Arg-Gly-Asp containing peptides from viper venom.Invest Ophthalmol Vis Sci, 1996; 37(5):843-53
    42.Mizejewski GJ,Role of integrins in cancer:survey of expression patterns.Proc Soc Exp Bio Med,1999;222(2):124-38
    43.Chiang HS,Peng HC,Huang TF.Characterization of integrin expression and regulation on sw-480 human colon adenocarcinoma cells and the effect of rhodostomin on basal and upregulated tumor cell adhesion. Biochim Biophys Acta,1994;1224(3):506-16.
    44.Chiang HS,Yang RS,Huang TF.Thrombin enhances the adhesion and migration of human colon adenocarcinoma cells via increased beta3-integrin expression on the tumor cell surface and their inhibition by the snake venom peptide.rhodostomin.Br J Cancer. 1996;73(7)902-8
    45.Fry B,Ritter MR,Markland FS.Inhibitory effects of a snake venom protein on the binding of breast cancer cells to extracelluar matrix components.Proc Am Assoc Cancer Res.1996;37:65-71.
    46.Sheu JR, Lin CH, Peng HC, et al. Triflavin, an ARG-Gly-Asp containing peptide, inhibits cervical carcinoma(Hela)cell- substratum adhesion through an RGD dependent mechanism.Peptides, 1994; 15(8): 1391-8.
    47.Mclane MA,Kuchar MA,Brando C et al.New insights on disintegrin- receptor interactions:eristostatin and melanoma cells. Haemostasis, 2001,31(3-6):177-82.
    48.Hynes RO.Integrins:bidirectional,allosteric signaling machines. Cell, 2002, 110(6);673-87.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700